Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E–deficient mice
Author:
Funder
Chinese PLA General Hospital
Publisher
Elsevier BV
Subject
Pharmacology,Molecular Medicine,Physiology
Reference33 articles.
1. Sitagliptin: a review in type 2 diabetes;Scott;Drugs,2017
2. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice;Matsubara;J. Am. Coll. Cardiol.,2012
3. Alogliptin, a dipeptidyl peptidase 4 inhibitor, prevents the progression of carotid atherosclerosis in patients With Type 2 diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A);Mita;Diabetes Care,2016
4. The pathobiology of diabetic complications: a unifying mechanism;Brownlee;Diabetes,2005
5. Atherosclerosis and cell cycle: put the brakes on! Critical role for cyclin-dependent kinase inhibitors;Wessely;J. Am. Coll. Cardiol.,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism;Journal of Cardiovascular Translational Research;2023-12-13
2. Sitagliptin Induces Tolerogenic Human Dendritic Cells;International Journal of Molecular Sciences;2023-11-27
3. Non-Specific Inhibition of Dipeptidyl Peptidases 8/9 by Dipeptidyl Peptidase 4 Inhibitors Negatively Affects Mesenchymal Stem Cell Differentiation;Journal of Clinical Medicine;2023-07-12
4. Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer;Physical Sciences Reviews;2023-05-11
5. Atherosclerosis: from the disruption of mitochondrial membrane potential to the potential interventional strategies;Current Medicinal Chemistry;2022-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3